⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NPCE News
Neuropace, Inc. Common Stock
Form 8-K
sec.gov
NPCE
NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy
businesswire.com
NPCE
Form 8-K
sec.gov
NPCE
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
businesswire.com
NPCE
Form 8-K
sec.gov
NPCE
NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
businesswire.com
NPCE
NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026
businesswire.com
NPCE
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026
businesswire.com
NPCE
NeuroPace to Present at the 25 th Annual Needham Virtual Healthcare Conference
businesswire.com
NPCE
Global Neuromodulation Closed-Loop Brain-Computer Interfaces Market Set for 16.4% CAGR Surge Through 2036, Led by the United States, India & China; Key Players Medtronic, NeuroPace, Synchron Drive Algorithm-Centric Innovation
accessnewswire.com
MDT
NPCE